Position in VRTX
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$14,006,791
+$1,661,301 QoQ
Shares Held
28,198
+2.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#309
of 1,735 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Avanza Fonder AB holds $21,519,303 across 6 Biotechnology names. VRTX ranks #1 (65.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
28,198 | $14,006,791 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,517 | $7,181,310 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
399 | $120,110 | |
| 4 | RPRX |
Royalty Pharma plc
|
1,649 | $92,458 | |
| 5 | INCY |
Incyte Corp
|
628 | $71,189 | |
| 6 | INSM |
INSMED Inc
|
445 | $47,445 |
All Filings in VRTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,006,791 | 28,198 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $12,345,490 | 27,647 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $12,505,934 | 27,585 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $10,595,036 | 27,053 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $11,319,209 | 25,425 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $11,645,375 | 24,020 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $11,339,225 | 28,158 | Shares | Sole | 2025-01-15 | |
| No filing history on record for this holder in this stock. | ||||||